Related Experiment Video
Updated: Aug 18, 2026
Ferric Chloride-induced Thrombosis Mouse Model on Carotid Artery and Mesentery Vessel
Published on: June 29, 2015
Effect of methylmercuric chloride (MMC) on fibrin polymerization
1Medical University, Department of Biochemistry, Lódz, Poland.
Abstract:
Methylmercuric chloride (MMC) in concentrations 0.1-10 microM reduces the amount of fibrinopeptides released from thrombin-activated human fibrinogen. However, the fibrin clot formation is not discriminated and the turbidity of the fibrin gel is even augmented. MMC does not cause such changes in the process of repolymerization of fibrin monomers. The addition of fibrinopeptides to the fibrin monomers results in a similar increase of turbidity of the repolymerizing sample in the presence of MMC as in the case of fibrinogen clotting. These experiments indicate that MMC modifies the structure of fibrin in the presence of fibrinopeptides.
Insights
Methylmercuric chloride (MMC) impacts blood clotting by altering fibrin structure. While reducing fibrinopeptides, MMC enhances fibrin gel turbidity, suggesting a direct modification of fibrin in the presence of these peptides.
Area of Science:
- Biochemistry
- Toxicology
- Hematology
Background:
- Fibrinogen is a key protein in blood coagulation.
- Fibrinopeptides are released during fibrin clot formation.
- Methylmercuric chloride (MMC) is a known toxicant.
Purpose of the Study:
- To investigate the effect of methylmercuric chloride (MMC) on fibrinogen clotting.
- To elucidate the mechanism by which MMC influences fibrin formation.
Main Methods:
- Studied the release of fibrinopeptides from thrombin-activated human fibrinogen.
- Assessed fibrin clot formation and turbidity.
- Examined the repolymerization of fibrin monomers with and without fibrinopeptides in the presence of MMC.
Main Results:
- MMC (0.1-10 microM) reduced fibrinopeptide release.
- Fibrin clot formation was not inhibited; turbidity increased.
- MMC did not affect fibrin monomer repolymerization alone.
- MMC increased turbidity during repolymerization in the presence of fibrinopeptides.
Conclusions:
- MMC alters fibrin structure, particularly in the presence of fibrinopeptides.
- The observed changes in clotting are likely due to MMC's interaction with fibrin structure, not just fibrinopeptide release inhibition.
